Accéder au contenu
Merck

Phosphofructokinase-1 Negatively Regulates Neurogenesis from Neural Stem Cells.

Neuroscience bulletin (2016-05-06)
Fengyun Zhang, Xiaodan Qian, Cheng Qin, Yuhui Lin, Haiyin Wu, Lei Chang, Chunxia Luo, Dongya Zhu
RÉSUMÉ

Phosphofructokinase-1 (PFK-1), a major regulatory glycolytic enzyme, has been implicated in the functions of astrocytes and neurons. Here, we report that PFK-1 negatively regulates neurogenesis from neural stem cells (NSCs) by targeting pro-neural transcriptional factors. Using in vitro assays, we found that PFK-1 knockdown enhanced, and PFK-1 overexpression inhibited the neuronal differentiation of NSCs, which was consistent with the findings from NSCs subjected to 5 h of hypoxia. Meanwhile, the neurogenesis induced by PFK-1 knockdown was attributed to the increased proliferation of neural progenitors and the commitment of NSCs to the neuronal lineage. Similarly, in vivo knockdown of PFK-1 also increased neurogenesis in the dentate gyrus of the hippocampus. Finally, we demonstrated that the neurogenesis mediated by PFK-1 was likely achieved by targeting mammalian achaete-scute homologue-1 (Mash 1), neuronal differentiation factor (NeuroD), and sex-determining region Y (SRY)-related HMG box 2 (Sox2). All together, our results reveal PFK-1 as an important regulator of neurogenesis.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-tubuline (isoforme bêta III, extrémité C-terminale), clone TU-20 (similaire à TUJ1), ascites fluid, clone TU-20 (Similar to TUJ1), Chemicon®
Sigma-Aldrich
Anticorps anti-protéine fluorescente verte, Chemicon®, from chicken
Sigma-Aldrich
Anticorps anti-BrdU, clone 131-14871, clone 131-14871, Chemicon®, from mouse